Shareen Cox

868 total citations
30 papers, 632 citations indexed

About

Shareen Cox is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Transplantation. According to data from OpenAlex, Shareen Cox has authored 30 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pediatrics, Perinatology and Child Health, 7 papers in Pharmacology and 7 papers in Transplantation. Recurrent topics in Shareen Cox's work include Pharmacological Effects and Toxicity Studies (9 papers), Renal Transplantation Outcomes and Treatments (7 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). Shareen Cox is often cited by papers focused on Pharmacological Effects and Toxicity Studies (9 papers), Renal Transplantation Outcomes and Treatments (7 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). Shareen Cox collaborates with scholars based in United States, Netherlands and Australia. Shareen Cox's co-authors include Alexander A. Vinks, Philip D. Walson, Tsuyoshi Fukuda, Michael T. Kelley, Mary Ellen Mortensen, Jens Goebel, Yasuhiro Suzuki, Joseph R. Sherbotie, John R. Hayes and Catherijne A. J. Knibbe and has published in prestigious journals such as CHEST Journal, Critical Care Medicine and The Journal of Pediatrics.

In The Last Decade

Shareen Cox

28 papers receiving 610 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shareen Cox United States 15 199 138 136 111 98 30 632
Steven A. Myre United States 13 190 1.0× 94 0.7× 133 1.0× 41 0.4× 12 0.1× 26 591
Elizabeth Ludwig United States 19 173 0.9× 239 1.7× 44 0.3× 100 0.9× 11 0.1× 59 1.1k
Ian S Westley Australia 12 378 1.9× 88 0.6× 521 3.8× 153 1.4× 20 0.2× 23 759
GJ Burckart United States 10 247 1.2× 64 0.5× 167 1.2× 28 0.3× 10 0.1× 13 581
Lawrence J. Hak United States 16 228 1.1× 54 0.4× 22 0.2× 82 0.7× 23 0.2× 46 872
Kyle Matschke United States 15 57 0.3× 83 0.6× 31 0.2× 40 0.4× 56 0.6× 60 545
J. C. Levron France 14 75 0.4× 64 0.5× 14 0.1× 77 0.7× 157 1.6× 36 702
A M Taburet France 19 236 1.2× 93 0.7× 118 0.9× 84 0.8× 5 0.1× 31 709
Antoni A Piergies United States 12 152 0.8× 187 1.4× 165 1.2× 71 0.6× 6 0.1× 19 639
László Asztalos Hungary 15 32 0.2× 61 0.4× 125 0.9× 44 0.4× 107 1.1× 60 622

Countries citing papers authored by Shareen Cox

Since Specialization
Citations

This map shows the geographic impact of Shareen Cox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shareen Cox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shareen Cox more than expected).

Fields of papers citing papers by Shareen Cox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shareen Cox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shareen Cox. The network helps show where Shareen Cox may publish in the future.

Co-authorship network of co-authors of Shareen Cox

This figure shows the co-authorship network connecting the top 25 collaborators of Shareen Cox. A scholar is included among the top collaborators of Shareen Cox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shareen Cox. Shareen Cox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Emoto, Chie, Tsuyoshi Fukuda, Tomoyuki Mizuno, et al.. (2014). Age-Dependent Changes in Sirolimus Metabolite Formation in Patients With Neurofibromatosis Type 1. Therapeutic Drug Monitoring. 37(3). 395–399. 11 indexed citations
2.
Cox, Shareen, Tsuyoshi Fukuda, Joseph R. Sherbotie, et al.. (2014). Effects of Unbound Mycophenolic Acid on Inosine Monophosphate Dehydrogenase Inhibition in Pediatric Kidney Transplant Patients. Therapeutic Drug Monitoring. 36(6). 716–723. 14 indexed citations
3.
Chidambaran, Vidya, Senthilkumar Sadhasivam, Jeroen Diepstraten, et al.. (2013). Evaluation of propofol anesthesia in morbidly obese children and adolescents. BMC Anesthesiology. 13(1). 8–8. 26 indexed citations
4.
Fukuda, Tsuyoshi, Jens Goebel, Shareen Cox, et al.. (2012). UGT1A9, UGT2B7, and MRP2 Genotypes Can Predict Mycophenolic Acid Pharmacokinetic Variability in Pediatric Kidney Transplant Recipients. Therapeutic Drug Monitoring. 34(6). 671–679. 43 indexed citations
5.
Diepstraten, Jeroen, Vidya Chidambaran, Senthilkumar Sadhasivam, et al.. (2012). Propofol Clearance in Morbidly Obese Children and Adolescents. Clinical Pharmacokinetics. 51(8). 543–551. 41 indexed citations
6.
Diepstraten, Jeroen, Vidya Chidambaran, Senthilkumar Sadhasivam, et al.. (2012). Propofol Clearance in Morbidly Obese Children and Adolescents. Clinical Pharmacokinetics. 51(8). 543–551. 6 indexed citations
7.
Fukuda, Tsuyoshi, Kristina Wiers, Shareen Cox, et al.. (2010). Pharmacokinetics and Pharmacodynamics of Mycophenolic Acid and Their Relation to Response to Therapy of Childhood-Onset Systemic Lupus Erythematosus. Seminars in Arthritis and Rheumatism. 40(4). 307–313. 48 indexed citations
8.
Fukuda, Tsuyoshi, Jens Goebel, Shareen Cox, et al.. (2010). Inosine Monophosphate Dehydrogenase (IMPDH) Activity as a Pharmacodynamic Biomarker of Mycophenolic Acid Effects in Pediatric Kidney Transplant Recipients. The Journal of Clinical Pharmacology. 51(3). 309–320. 47 indexed citations
9.
Cox, Shareen, et al.. (2007). Determination of risperidone and enantiomers of 9-hydroxyrisperidone in plasma by LC-MS/MS. Journal of Chromatography B. 852(1-2). 497–504. 42 indexed citations
10.
Walson, Philip D., Shareen Cox, Ilya Utkin, et al.. (2003). Clinical Use of a Simultaneous HPLC Assay for Indinavir, Saquinavir, Ritonavir, and Nelfinavir in Children and Adults. Therapeutic Drug Monitoring. 25(5). 588–592. 5 indexed citations
11.
Jones, James W., Philip D. Walson, & Shareen Cox. (1999). AN ASSESSMENT OF THE ENVIRONMENTAL CONTAMINATION BY AEROSOLIZED TOBRAMYCIN IN A PEDIATRIC PULMONARY UNIT. Therapeutic Drug Monitoring. 21(4). 455–455. 1 indexed citations
12.
Kelley, Michael T., Philip D. Walson, Shareen Cox, & Leon J. Dusci. (1997). Population Pharmacokinetics of Felbamate in Children. Therapeutic Drug Monitoring. 19(1). 29–36. 19 indexed citations
13.
Nahata, Milap C., et al.. (1997). Pharmacokinetics and Safety of Tobramycin After Once-Daily Administration in Patients With Cystic Fibrosis. CHEST Journal. 112(5). 1208–1213. 43 indexed citations
14.
Cox, Shareen, et al.. (1996). Serum lidocaine concentrations after subcutaneous administration in patients undergoing cardiac catheterization in a pediatric institution. The Journal of Pediatrics. 129(3). 464–466. 5 indexed citations
15.
Cox, Shareen, et al.. (1995). Pharmacokinetics of phenytoin in children with acute neurotrauma. Critical Care Medicine. 23(8). 1418–1424. 9 indexed citations
16.
Suzuki, Yasuhiro, et al.. (1994). Phenytoin Age-Dose-Concentration Relationship in Children. Therapeutic Drug Monitoring. 16(2). 145–150. 19 indexed citations
17.
Cox, Shareen, et al.. (1993). Audit of Theophylline Plasma Level Monitoring in a Pediatric Hospital. Therapeutic Drug Monitoring. 15(4). 289–293.
18.
Suzuki, Yasuhiro, et al.. (1991). Valproic Acid Dosages Necessary to Maintain Therapeutic Concentrations in Children. Therapeutic Drug Monitoring. 13(4). 314–317. 10 indexed citations
19.
Suzuki, Yasuhiro, Shareen Cox, John R. Hayes, & Philip D. Walson. (1991). Carbamazepine Age-Dose Ratio Relationship in Children. Therapeutic Drug Monitoring. 13(3). 201–208. 28 indexed citations
20.
Cox, Shareen & Philip D. Walson. (1989). Providing Effective Therapeutic Drug Monitoring Services. Therapeutic Drug Monitoring. 11(3). 310–322. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven A. Myre Breakdown of academic impact, for papers by Elizabeth Ludwig Breakdown of academic impact, for papers by Ian S Westley Breakdown of academic impact, for papers by GJ Burckart Breakdown of academic impact, for papers by Lawrence J. Hak Breakdown of academic impact, for papers by Kyle Matschke Breakdown of academic impact, for papers by J. C. Levron Breakdown of academic impact, for papers by A M Taburet Breakdown of academic impact, for papers by Antoni A Piergies Breakdown of academic impact, for papers by László Asztalos
Rankless by CCL
2026